SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Knight-Klimas, T. C.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Current Management of Urinary Incontinence

Tanya C. Knight-Klimas, Pharm D, CGP, FASCP

Temple University School of Pharmacy, Philadelphia, tanya.knight{at}temple.edu

Urinary incontinence is an underreported, underdiagnosed, and undertreated condition erroneously thought by many patients to be a normal part of aging. This article briefly discusses transient urinary incontinence and then focuses on the different types of established incontinence. Specifically, the article discusses preferred terminology associated with urinary incontinence and describes the different types, causes, nonpharmacologic options, and pharmacologic options for managing overactive bladder syndrome, stress incontinence, and overflow incontinence. It briefly discusses mixed urinary incontinence and functional incontinence. The role of the pharmacist in working with patients, caregivers, and other health care professionals to optimize management of urinary incontinence is discussed throughout.

Key Words: Urinary incontinence • overactive bladder syndrome • overflow incontinence • oxybutynin • tolterodine

Journal of Pharmacy Practice, Vol. 17, No. 2, 103-114 (2004)
DOI: 10.1177/0897190004263216


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement